Nuvalent, Inc. (NUVL) Social Stream
NUVALENT INC (NUVL) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NUVALENT INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 3 | $42 | $35 | $38.5 | $72.35 | -46.79% |
| 2022-03-29 | 3 | $42 | $38 | $40 | $72.35 | -44.71% |
| 2022-05-12 | 3 | $42 | $31 | $36.5 | $72.35 | -49.55% |
| 2022-05-13 | 3 | $42 | $27 | $34.5 | $72.35 | -52.32% |
| 2022-08-11 | 4 | $42 | $27 | $32.333 | $72.35 | -55.31% |
| 2022-11-04 | 3 | $42 | $27 | $32.333 | $72.35 | -55.31% |
| 2022-11-11 | 3 | $42 | $28 | $35.666 | $72.35 | -50.7% |
| 2023-01-17 | 4 | $42 | $28 | $36.5 | $72.35 | -49.55% |
| 2023-03-16 | 4 | $45 | $28 | $37.25 | $72.35 | -48.51% |
| 2023-05-11 | 4 | $53 | $28 | $40.75 | $72.35 | -43.68% |
| 2023-06-23 | 3 | $53 | $45 | $48.666 | $72.35 | -32.74% |
| 2023-07-24 | 5 | $56 | $45 | $50.5 | $72.35 | -30.2% |
| 2023-08-08 | 5 | $56 | $42 | $48.8 | $72.35 | -32.55% |
| 2023-08-22 | 5 | $56 | $42 | $50.6 | $72.35 | -30.06% |
| 2023-09-07 | 6 | $56 | $42 | $51.2 | $72.35 | -29.23% |
| 2023-09-29 | 6 | $65 | $42 | $53.5 | $72.35 | -26.05% |
| 2023-10-05 | 7 | $73 | $42 | $60.428 | $72.35 | -16.48% |
| 2023-10-06 | 7 | $73 | $42 | $62.714 | $72.35 | -13.32% |
| 2023-10-16 | 7 | $100 | $56 | $72.857 | $72.35 | 0.7% |
| 2023-10-19 | 7 | $100 | $56 | $73.714 | $72.35 | 1.89% |
The Trend in the Analyst Price Target
Over the past 31 weeks, NUVL's average price target has gone up $36.46.
Over the past 39 weeks, NUVL's average upside potential has been 12.98%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-16 | 4 | 45 | 28 | 37.250 | 29.62 | 25.76% |
| 2023-05-11 | 3 | 53 | 37 | 45.000 | 40.09 | 12.25% |
| 2023-09-29 | 6 | 65 | 42 | 53.500 | 45.97 | 16.38% |
| 2023-10-05 | 7 | 73 | 42 | 58.000 | 62.41 | -7.07% |
| 2023-10-06 | 7 | 73 | 42 | 62.714 | 64.52 | -2.8% |
NUVL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.25 | 7 | 0 | 1 | 0 | 0 | 8 |
The Trend in the Broker Recommendations
Over the past 39 weeks, NUVL's average broker recommendation rating worsened by 0.29.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how NUVALENT INC fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is greater than 162.26% of that group.
- In terms of how NUVALENT INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 517.06% of that group.
- In terms of how NUVALENT INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -565.24% of that group.
- NUVL has a higher average analyst price target than 1857.25% of Pharmaceutical Products stocks.
In the Pharmaceutical Products industry, VTYX, BHVN, and GPCR are the three stocks most similar to NUVALENT INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Is NUVL a Buy, Hold or Sell? See the POWR Ratings now!